The contribution of Mycobacterium bovis to the global burden of tuberculosis (TB) in man is likely to be underestimated due to its dysgonic growth characteristics and because of the absence of pyruvate in most used media is disadvantageous for its primary isolation. In Brazil Mycobacterium culture, identification and susceptibility tests are performed only in TB reference centers, usually for selected cases. Moreover, solid, egg-based, glycerol-containing (without pyruvate supplementation) Löwenstein-Jensen (L-J) or Ogawa media are routinely used, unfavouring M. bovis isolation. To determine the importance of M. bovis as a public health threat in Brazil we investigated 3046 suspected TB patients inoculating their clinical samples onto routine L-J and L-J pyruvate enriched media. A total of 1796 specimens were culture positive for Mycobacterium spp. and 702 TB cases were confirmed. Surprisingly we did not detect one single case of M. bovis in the resulting collection of 1674 isolates recovered from M. bovis favourable medium analyzed by conventional and molecular speciation methods. Also, bacillary DNA present on 454 sputum smears from 223 TB patients were OxyR genotyped and none was recognized as M. bovis. Our data indicate that M. bovis importance on the burden of human TB in Brazil is marginal.
Introduction
Tuberculosis (TB) is primarily a disease of the lung, caused by very closely related mycobacteria belonging to the Mycobacterium tuberculosis complex (MTC). The complex includes the following species: M. tuberculosis, Mycobacterium africanum, Mycobacterium bovis, and M. bovis-BCG, Mycobacterium microti, Mycobacterium caprae, Mycobacterium pinnipedii, and Mycobacterium canettii.
1e3 By far, the most important agent of human tuberculosis is M. tuberculosis, accountable for more than 90% of cases. 4 Whereas M. tuberculosis is mainly a human pathogen, M. bovis has a broader host range, being mostly observed in cattle but sometimes reported as responsible for disease in other species. Noteworthy, M. bovis is naturally resistant to pyrazinamide, a first-line anti-TB drug. 5 Therefore, M. bovis detection, beyond its importance in the identification of outbreaks and epidemiological links, has also implications for planning the most appropriate anti-TB therapeutic regimen and public healthy interventions.
In the case of human TB, M. bovis is reported worldwide as being the second most frequent causative agent, estimated as being responsible for approximately 5% of the global tuberculosis cases. 6 Infection with M. bovis has accounted for a proportion ranging from 0.5 to 7.2% of all patients with a bacteriologically proven tuberculosis in industrialized countries. 7 However, it is generally though that in developing countries, M. bovis infection constitutes a more severe threat to public health and might account for up to 10e15% of the yearly registered new cases of human tuberculosis.
6e8
Human infection with M. bovis is mostly due to ingestion of unpasteurized milk or, alternatively, inhalation of droplet nuclei. 7, 8 Although the anatomic site of human M. bovis disease is more often extra-pulmonary, human disease caused by M. bovis and M. tuberculosis are clinically, radiologically, and histopathologically indistinguishable. 9, 10 Therefore, pathogen differentiation at species level requires the observation of phenotypic characteristics that include colony morphology, growth rate, and biochemical properties after culturing on appropriate medium. 10 In most developing countries, diagnosis of human TB is based on direct microscopic examination of specimens after acid-fast staining and chest radiography. Some TB reference laboratories perform culture on the Mycobacterium selective Löwenstein-Jensen (L-J) medium and biochemical tests to differentiate isolates, eventually including some that distinguish M. tuberculosis from M. bovis. However, even in these laboratories the use of the egg-medium containing pyruvate and semi-synthetic media in which the bovine bacillus would preferably grow is greatly limited. 11 Hence, the difficulty in obtaining primary isolates of M. bovis using conventional L-J medium is a major obstacle to ascribe the contribution of M. bovis to the burden of human TB in developing countries. To investigate the role of M. bovis in the etiology of human tuberculosis cases in Brazil, particularly in Rio de Janeiro, we conducted a study that added to conventional mycobacterial culturing and identification procedures, culturing on glycerol-free pyruvate containing L-J medium and genetic analysis. Additionally we performed direct genotyping of material present on ZiehleNeelsen (ZeN) stained slides that had been prepared as part of standard TB diagnostic workout.
Materials and methods

Study setting and design
Virtually all commercially available milk supply is pasteurized in Brazil. Estimated Brazilian bovine population is 195 millions and the prevalence of tuberculin reactors animals range between 0.37% (in the Southern-Eastern) and 3.62% (in the Northern States). 12 Around 20% of Brazilian dairy cattle farms are thought to be affected by bovine tuberculosis. In a survey conducted in Rio de Janeiro state 12.7% of tested animals were tuberculin reactors. 13 However, the magnitude of bovine tuberculosis may be yet more serious in Brazil. Isolated animals and small herds, in areas comprising subsistence farming and pastoral communities, are usually not tested for M. bovis infection. Such areas are present even in the periphery of Brazilian metropolitan regions and people living in these areas may be exposed to unpasteurized milk and dairy products and meat of infected animals. World Health Organization estimated as 92,000 the number of new human TB cases in Brazil for 2007 (an incidence rate of 48 per 100,000 individuals). The overall estimated prevalence of M. tuberculosis infection among adults was 60 per 100,000 inhabitants. The mortality rate from tuberculosis in Brazil was estimated to be 4.4 per 100,000 persons (8400 deaths/year in 2007).
14 Approximately 14% of adults with TB are thought to be HIV positive, and an estimated 20% of people living with HIV/AIDS have pulmonary tuberculosis. 15 Rio de Janeiro is the second largest city in Brazil, with 
Handling of clinical specimens and culture conditions
As it is generally believed that M. bovis growth or, at least, optimal growth is constrained by using media without pyruvate supplementation and/or containing glycerol, we performed, in parallel to culturing on conventional L-J medium supplemented with glycerol, inoculation of all clinical specimens on tubes with L-J that was free of glycerol and supplemented with 5 mg/ml sodium pyruvate (SigmaeAldrich, St. Louis, Missouri, USA). We collected a total of 8833 specimens from 3046 suspected TB patients and replicate patient samples were due either because of collection from different body sites and/or on different days. The median number of samples collected per patient was three. For culturing, clinical specimens were homogenized, submitted to N-acetyl-cysteine digestion and sodium hydroxide decontamination and centrifuged 2 times at 3000g for 15 min. Aseptically collected fluids and tissues were centrifuged without previous digestion or decontamination. The sediment was resuspended and divided into three equal volumes.
Two 200 ml aliquots were plated onto L-J. 16 The third aliquot were plated onto L-J, without glycerol, pyruvate enriched agar slants (L-J pyruvate). All inoculated slants were incubated at 37 C for eight weeks and submitted to standardized observation protocol, after 48e72 h, and later on twice weekly. After 60 days, bacterial counts were defined by colony numbering from 1 to 19, or scored þ1 (20e100 colonies), þ2 (>100 individual colonies) or þ3 (confluent colonies). 17 Growth on the L-J slants resembling mycobacterial colonies (i.e., rough, tough and buff-colored), was subjected to ZeN staining and Gram staining to confirm the presence of acid-fast bacilli and rule out contamination. As a control procedure, we also inoculated four M. 
Phenotypic and biochemical characterization of bacterial isolates
For differentiation of Mycobacterium spp. of the MTC from mycobacteria other than tuberculosis (MOTT), we observed characteristics based on pigmentation, colony morphology, speed of growth and biochemical tests. 17, 18 Differentiation between some of the MTC members was achieved by analyzing phenotypical and biochemical features, including production of niacin, nitrate reduction, semi-quantitative catalase activity and catalase thermo stability at 68 C, as previously described by Kent & Kubica. 17 
Genotyping
For genotyping of MTC DNA present in cultures a loop of bacterial mass was taken from cultures in L-J pyruvate medium, suspended in 0.5 ml of 10 mM Tris-HCle1 mM EDTAe1% Triton X-100 and incubated at 100 C for 10 min after vigorous mixing. Nucleic acids and processed cultures were stored at À20 C until further use. Spoligotyping was performed using PCR and hybridization conditions on a commercially available membrane (Isogen Bioscience BV, Maarssen, The Netherlands) as previously described 19 and including (M. tuberculosis and M. bovis DNA) controls in every batch of tests. As a supplementary test for differentiation of M. tuberculosis from M. bovis, we performed PCR-REA of a 726 bp fragment including the full pncA gene (561 bp) as described by Barouni et al. 20 The pncA gene contains a polymorphic site at position 169 that permits the distinction between M. bovis and M. tuberculosis. In brief, the 726 bp fragment was generated using the primers 5 0 GTC GGT CAT GTT CGC GAT CG 3 0 and 5 0 GCT TTG CGG CGA GCG CTC CA 3 0 . 20 Thermal cycling conditions were: initial denaturation at 95 C for 4 min; followed by 35 cycles of denaturation at 94 C for 1 min, annealing at 68 C for 2 min and extension at 72 C for 1 min. An additional extension step at 72 C for 10 min was included at the end of 35-th cycle. PCR amplifications were digested with Eco065 I and resolved on a 5% agarose to determine the presence of the allelic variant of M. Bovis. In addition to the genotyping of the clinical samples described above, we also performed genetic characterization of bacilli present in 454 ZeN stained sputum smears corresponding to 223 pulmonary TB cases. Patients were from two different Brazilian regions, including 140 (303 positive ZeN slides) from Campos, Rio de Janeiro State and 83 (151 positive ZeN slides) from four municipalities of the Minas Gerais State. The presence of acid-fast bacilli (AFB) was quantified by microscopy and recorded as þ (less than 1 bacillus per 100 examined fields), þþ (1e10 bacilli per 50 examined fields) and þþþ (more than 10 bacilli per 20 examined fields). The slides had been stored at room temperature for no longer than eight weeks before DNA extraction, the latter achieved by a procedure adapted from van der Zend et al. 21 Briefly, residual oil present on the glass slides was removed with xylol (Merck, Darmstadt, Germany), rinsed with distilled water and the biological material removed from the surface by scraping with a #14 lancet after spotting 25 ml of sterile distilled water. This suspension was transferred to a microcentrifuge tube containing 200 ml of a 15%
Chelex 100 (SigmaeAldrich, St. Louis, Missouri, USA) suspension and after vigorous shaking, incubated at 95 C for 30 min. The samples were then centrifuged for 10 min at 13,000g and the supernatant removed and stored at À20 C until further analysis. As single point mutations of the pncA gene 5 has been used to differentiate between M. bovis and M. tuberculosis PCRs were performed to amplify a 726 bp fragment including the full pncA gene. Almost all pncA PCRs failed to amplify. Assuming that the mycobacterial DNA present on the ZeN stained slides could have been significantly degraded, we realized that PCR amplification of targets of more than 150e200 bp may be difficult. For this reason we used primers previously described by Taylor et al. for amplifying a smaller 150 bp oxyR gene fragment 22 and determine nucleotide at oxyR gene position 285 to differentiate M. bovis from M. tuberculosis. 23 The sequence of these primers is 5 0 CGCGCTGTCA-GAGCTGACTTT 3 0 (forward) and 5 0 TCTGCGGAATCAGTGTCACC 3 0 (reverse). The cycling conditions were: initial denaturation at 94 C for 1 min; followed by 45 cycles consisting of 1 min at 94 C, 1 min at 60 C, 1 min at 72 C. An additional extension step at 72 C for 10 min was included at the end of 45-th cycle. After agarose gel electrophoresis, the 150 bp amplicon was purified and the presence of the single nucleotide A/G polymorphism at position 285, distinctive of M. bovis, was verified by sequencing. Sequencing reactions were performed using the BigDye Terminator 3.1 Cycle Sequencing kit and electrophoresis was performed under standard conditions on an ABI 3730 automated sequencer (Applied Biosystems). The sequence data were analyzed with SeqScape software version 2.5 (Applied Biosystems) and compared with the published sequence of oxyR (GenBank accession number U18263).
Data analysis
The two-proportion Z-test was used to compare mycobacterial growth on the different media used in the study. Fisher's exact test was used to compare the number of pulmonary and extra-pulmonary isolates that grew on L-J medium with those that grew exclusively L-J pyruvate medium. A significance level of 5% was considered. Spoligotype patterns were recorded both in a 43-digit binary format representing the 43 spacers and as an octal code 24 and initially verified for the presence of spacers that differentiate M. tuberculosis from M. bovis. In addition, M. tuberculosis patterns were introduced into a Microsoft Office Excel datasheet for cluster recognition and classification and then compared with the SpolDB4 database of the Pasteur Institute of Guadeloupe (http://www.pasteur-guadeloupe.fr: 8081/SITVITDemo) for type classification. All isolates that yielded spoligotypes that were recognized as not previously described patterns were submitted to at least one additional spoligotyping assay and only considered when confirming the first pattern.
Results
3.1.
Mycobacterial growth on routine L-J and L-J pyruvate medium 3.1.1. Control strains As someone could argue that inherent problems within the pyruvate supplemented medium might account for the failure of M. bovis "truly" positive specimens to yield identifiable mycobacterial growth we carried out a growth control assay. Standard collection and clinical MTC strains were inoculated on L-J and L-J pyruvate. Their growth rates on each and both media are shown in Table 1 . All tested M. bovis reference strains grew adequately on pyruvate supplemented media.
Clinical specimens strains
From the 26,499 slants that were inoculated with 8833 clinical specimens from 3046 suspected TB cases 17,666 cultures on routine L-J and 8833 cultures on L-J supplemented with pyruvate, were observed during a 60 days period. Overall, 1796 clinical specimens out of 8833 (20.3%) produced 3365 positive mycobacterial cultures in one or both media. Most of specimens (1593, 88.6%) were pulmonary while 203 (11.4%) % were obtained from an extra-pulmonary site. The majority of the isolates (3001, 89.2%) were obtained from the 1593 pulmonary specimens. Among the pulmonary isolates, 66% originated from sputum, 27.1% from induced sputum, 6.9% from bronchoalveolar lavage fluid and 1% from other related specimens. An extra-pulmonary site was the origin of 364 (10.8%) isolates recovered from 203 samples. Taking into account the sum of extra-pulmonary isolates, 28% originated from lymph nodes, 27% from blood or bone marrow, 12% from pleura and the remaining 33% from various other tissues. Table 2 Five-fold more extra-pulmonary mycobacterial isolation was observed exclusively on L-J pyruvate than exclusively on L-J medium (p-value < 0.001). Also, when comparing the number of pulmonary and extra-pulmonary strains that grew on L-J with those that grew exclusively L-J pyruvate (shown in Table 2 ), we observed a statistically significant higher number of extrapulmonary strains recovery exclusively from L-J pyruvate medium (70/1523 versus 35/203, respectively for pulmonary and extrapulmonary strains [p < 0.001]). No such difference was observed in the case of inoculates derived from pulmonary specimens.
Phenotypic and biochemical characterization of isolates
The great majority (1678, 93.5%) of the 1796 culture positive specimens resulted on the isolation of 3182 strains that were typed as MTC spp. while 118 (6.5%) resulted on the isolation of 183 MOTT strains. Most of MOTT isolates were recognized among pulmonary samples (108/118, 91.5%) and only 10 among extra-pulmonary ones (8.5%). Overall, considering the 3365 strains that grew on L-J pyruvate and/or L-J standard media, 183 (5.4%) were identified as MOTT and 3182 (94.6%) as MTC spp. It is noteworthy that inoculation on L-J pyruvate medium did not particularly favored growth or recovery of MOTT strains neither from pulmonary nor extrapulmonary sites (data not shown). None of the 1674 mycobacterial isolates obtained from L-J pyruvate was identified as being M. bovis. All MTC isolates (from one or both media) presented values of phenotypic features and biochemical tests indicative of M. tuberculosis. Data concerning details about possible intermediate strains or grouping of isolates characteristics will be discussed elsewhere (manuscript in prep.). As it is commonly accepted that M. bovis growth or, at least, optimal growth is constrained by using media without pyruvate supplementation and/or containing glycerol, we performed the rest of the analytical procedures aimed at the identification of M. bovis as an etiologic agent of human TB only on isolates recovered from the L-J pyruvate, glycerol free medium.
Genotyping of bacterial isolates recovered from L-J pyruvate medium of patients from Rio de Janeiro
Among the 1674 isolates that were observed on L-J pyruvate 239 (14.2%) could not be submitted to genetic analysis, due medium degradation, contamination or loss during transfer and storage (153/239, 64%) or were excluded because they were identified as MOTT (86/239, 36%). The rest (n ¼ 1435) was submitted to genotyping using the assays for pncA and spoligotyping. Workable PCR amplification and RFLP analysis of the pncA gene polymorphic site at position 169 was obtained for 1161 (81%) of the 1435 isolates and all showed the M. tuberculosis pattern. Good quality spoligo patterns were generated for 989 (69%) of the isolates and all presented genotypes characteristic for M. tuberculosis (using as reference data available on SpolDB4) 24 and SITVIT databases (http://www.pasteurguadeloupe.fr:8081/SITVITDemo/). Data on genotyping outcome and source of the 1674 mycobacterial isolates recovered from L-J pyruvate medium are summarized in The number of isolates is given (followed in parentheses by the percentage) in relation to the number of pulmonary (row 1), extra-pulmonary (row 2) and total (row 3) of culture positive specimens. All 1796 culture positive specimens were obtained from 702 TB cases and 78 cases of MOTT infection enrolled at Rio de Janeiro. 
Genotyping of MTC present on ZiehleNeelsen stained smears
Mycobacterial DNA was obtained directly from AFB positive sputum smears produced during routine TB diagnosis workup in two different Brazilian regions (Campos, Rio de Janeiro State and four municipalities in the State of Minas Gerais) where cultures were not available. At first, we attempted to differentiate between M. bovis and M. tuberculosis as the mycobacterial species present on the sputum smears pointing out the distinctive pncA gene single nucleotide point mutation at position 169. However, in our hands almost all pncA PCRs failed to amplify directly from smears. The few pncA gene fragments (726 bp) that were successful amplified presented the M. tuberculosis pattern. Next, a smaller, 150 bp, oxyR gene fragment was amplifyed 22 and nucleotide at position 285 determined by sequence analysis to identify the species. 23 The oxyR genotyping fragment was successfully amplified and sequenced in 122 of the 303 (40%) AFB positive smears, corresponding to 49 of the 140 (35%) Campos TB patients and in 91 of the 151 (60%) AFB positive smears, corresponding to 58 of the 83 (69.8%) Minas Gerais TB patients. In all 213 successfully oxyR genotyped positive sputum smears, corresponding to 107 TB cases, the G nucleotide at position 285, characteristic of M. tuberculosis, was determined. Data on genotyping outcome of the 454 ZeN stained smears obtained from 223 pulmonary TB patients are summarized in Table 5 .
Discussion
Human disease caused by M. bovis and other species of the MTC are similar, although the anatomic site of M. bovis disease is more often extra-pulmonary. Thus, collecting clinical samples from extrapulmonary sites is an excellent strategy to identify cases of M. bovis human disease. Cases of human TB with M. bovis are mainly associated with the consumption of unpasteurized dairy products or close contact with infected animals. 7 Nevertheless, epidemiologic evidence supports the likelihood of human-to-human, airborne M. bovis contagion 25e28 and this issue has been considered as possibly relevant to the epidemiology and dynamics of human tuberculosis, at least in developing countries. Thus, studies aimed at the identification of the bovine bacillus in both, extra-pulmonary and respiratory samples, would be helpful to better understand the role of M. bovis as an etiologic agent of human TB. Results from a study comparing spoligo patterns indicate that the population of M. bovis strains causing human TB disease in Southern California is closely related to the M. bovis strain population found in Mexican cattle suggesting that human M. bovis disease in San Diego likely originated from Mexican cattle. 28 A recent report describes an outbreak of sputum-positive M.
bovis disease transmitted by person-to-person contact in United Kingdom. 27 Moreover, Etchechoury et al. studying samples from 448 TB patients from different regions of Argentina, identified 400 isolates with representative PRA (PCR-restriction fragment analysis patterns of mycobacterium. Further analysis of samples with MTC profiles identified nine M. bovis strains indicating that that 2% of pulmonary tuberculosis was due to M. bovis. 29 In developing countries M. bovis infection is highly prevalent in farmed animals 13 and its contribution to the burden of human TB in these regions could be more important than it is generally thought. Also, it is well known that co-infection with HIV favors M. bovis transmission leading rapidly to disease development 30, 31 and the high rates of HIV infection seen in most of the developing countries may increase the risk for the development human TB due to M. bovis. M. bovis grows poorly, or not at all, on standard glycerol-containing media but its growth is stimulated by sodium pyruvate. The pyruvate requirement of most M. bovis strains is the basis of one of the major phenotypic differences between M. bovis and M. tuberculosis and seems to be due to a point mutation in the pyruvate kinase gene, resulting in a defective glycerol metabolism. 32 Löwenstein-Jensen with pyruvate (but without glycerol), Stonebrink, modified Middlebrook 7H11 and tuberculosis bovine blood agar are considered the media of choice for the primary isolation of M. bovis. 33 We hypothesized that the extensive use of unfavourable media for M. bovis coupled with limited use of discriminatory biochemical and genotypic tests should be considered as a potential cause of under-reporting of M. bovis-related human disease. In this table) , from a total of 3365 isolates which were recovered from 1796 culture positive samples, corresponding to 702 TB patients and 78 cases of MOTT infection.
y All patients and samples were enrolled at Rio de Janeiro. { The number of isolates is given (followed in parentheses by the percentage) in relation to the total number of L-J isolates (column 1, lines 2 and 3), to the total of 1435 isolates submitted to spoligotyping (column 1, lines 4 and 5) and to the number of isolates stated in the column 1 (columns 3 and 4).
** 153 isolates were excluded due medium degradation, contamination or loss during transport/storage and 86 because they were identified as MOTT.
z Spoligotyping and pncA genotyping were performed only on MTC isolates recovered from the L-J pyruvate medium. This trend of some extra-pulmonary strains to preferentially grow on L-J pyruvate medium could be due to: i) the higher proportion of extra-pulmonary isolates that, as most M. bovis strains, could also intrinsically present lesions in carbohydrate catabolism, namely glycerol kinase and/or pyruvate kinase null or defective activity; ii) pyruvate supplementation might favor bacterial recovery from the usually paucibacillary extra-pulmonary specimens enhancing growth performance of small inoculi even of Mycobacterium spp. not possessing intrinsic defects in carbohydrate metabolism.
Isolates of the MTC may be classified according to their phenotypic characteristics or biochemical properties as strains that completely fulfill the criteria for M. tuberculosis or M. bovis. For such strains, no further characterization is usually performed. Nevertheless, some strains do not match all the required diagnostic criteria and produce atypical phenotypic and biochemical identification test results. Sometimes the differentiation between these two close-related MTC species (>99.95% of genome sequence identity) by using classical methods may pose a challenge to the microbiologist and could generate misleading results. 34, 35 Spoligotyping is considered as a reliable confirmatory genetic means for the differentiation between M. bovis and M. tuberculosis and it is particularly useful for strains with atypical biochemical identification test results. 35 For this reason, after the initial phenotypic and biochemical characterization, 1435 isolates recovered from the L-J glycerol free, pyruvate supplemented medium were submitted to spoligotyping. Patterns, adequate for analysis, were generated for 989 (69%) of these isolates. All of them were confirmed as MTC but none was marked by the distinct loss of spacers 3, 9, 16 and 39e43, individually or grouped, characteristic of M. bovis. 24 Actually, all successfully spoligotyped isolates were identified as M. tuberculosis. As samples were not selected for any particular purpose the 989 successfully spoligotyped strains and their spoligopatterns should be representative of the whole sample collection. However, it is possible that some of the strains not yielding spoligotyping were in fact M. bovis.
Using the spoligotyping technique, differentiation of MTC strains up to a subspecies level is also possible. 24 Extending the search for human M. bovis TB cases to eco-epidemiological settings where the risk of M. bovis infection is thought to be greater than in Rio Metropolitan area, we also investigated samples from other two Brazilian regions and their rural areas harboring important dairy cattle activities and presenting high index of cattle M. bovis infection. As the L-J pyruvate supplemented media and even L-J solid media cultures are not available as a standard procedure during the TB diagnostic work in these municipalities of Rio de Janeiro and Minas Gerais States, we performed direct OxyR genotyping from 454 AFB positive ZiehleNeelsen stained slides (303 from Campos and 151 from Minas Gerais, corresponding to 223 pulmonary TB patients) to identify any possibly present M. bovis strain. The oxyR 150 bp gene fragment was successfully amplified and sequenced from AFB-positive smears of 47.9% of the 223 studied pulmonary TB patients and in none, we observed the presence of the A nucleotide at position 285, typical for M. bovis.
It is somewhat surprising that not a single case of M. bovis-related TB was evidenced among the 1678 MTC culture positive samples from 702 TB patients, particularly considering that: i) a M. bovis favourable medium was systematically used in the study ii) the strains were isolated from 3046 suspected TB cases (702 confirmed) and a large number (n ¼ 8833) of clinical specimens representative of a broad spectrum of tissues and sites, including lymph nodes, bone marrow, blood, bone and bowel biopsies; ii) the University Hospital being a regional and national reference for TB, AIDS, immuno-inflammatory diseases and hematological malignancies an important proportion of examined specimens were originated from immunosupressed patients and iii) the University Hospital Gastroenterology Clinic being a regional reference for cases of infectious, granulomatous and inflammatory bowel diseases several of such cases are routinely under diagnostic investigation that not rarely includes mycobacterial cultures. Also, as many of developing or transition countries and regions, Brazil, and particularly Rio de Janeiro Metropolitan area and State, present high prevalence of both bovine and human TB and seems to present predisposing conditions for the development of human M. bovis infection and disease. Although almost all commercially available milk is pasteurized in Brazil it was recently reported that 11 of 128 (8.5%) bovine milk samples from retail markets in the State of São Paulo were contaminated by M. bovis. 38 In addition, small cow herds may be found scattered all over the country, even in peripheral regions of great cities like Rio. Small herd surveillance for infectious diseases presents problems in developed 39 and developing countries and is certainly much more difficult to be accomplished in countries like Brazil. Actually, in Brazil, for such dispersed cow or cows this surveillance may be completely non-existent. Moreover, a clearly defined slaughtering policy is not adopted in most Brazilian regions so people living in these areas are probably exposed to unpasteurized milk, unpasteurized dairy products and meat from infected animals. Even so, only few M. bovis-related TB cases have been reported in Brazil 11 and this picture remains unchanged even when lymph nodal and intestinal TB, TB associated with HIV and other immunosuppressive conditions and TB cases from Brazilian rural areas displaying poor economic indexes are taken in account. In a retrospective survey, Kantor et al. reported that the proportion of M. bovis-related human TB cases in 10 South America countries ranged from 0% to 2.5%. 11 Except for two cases from Ecuador, three from Brazil and one from Venezuela, all reported M. bovis TB cases were diagnosed in Argentina. Apparently in the other six investigated countries (Chile, Colombia, Costa Rica, Dominican Republic, Peru and Uruguay) M. bovis has never been isolated from humans.
11
As vaccination with M. bovis BCG was introduced in Brazil in 1940 and has been systematically administered to virtually all infants since 1976, some particular degree of specific protection against the bovine tubercle bacillus provided by this thorough vaccination might be one possible explanation for the paucity of M. bovis TB cases reported in our country. Nevertheless, most expert comments on the burden of M. bovis in human TB emphasize that the problem is most probably underestimated due to the limited use of M. bovis favourable media and the inherent complexities of phenotypical and biochemical speciation within the MTC. 11 For this reason, our study design was optimized for culturing and identification of MTC species, using conventional and molecular tools, and the fact that we did not detect one single case of M. bovis in such a large sample collection indicates that M. bovis importance on the burden of human TB in Brazil is marginal.
